Renal/Urology · PANCE / PANRE

Urinary Incontinence (Stress, Urge, Overflow)

Involuntary loss of urine; classified by mechanism into stress, urge, mixed, and overflow.

Also known as: urinary incontinence, stress incontinence, urge incontinence, overactive bladder, overflow incontinence

Overview

Involuntary leakage of urine. Categorized by mechanism: stress (with increased intra-abdominal pressure), urge (sudden compelling need with leakage — overactive bladder), mixed (features of both), overflow (incomplete emptying with continuous dribbling), and functional (intact urinary system but barriers to toileting).

Epidemiology

Affects ~20-50% of community-dwelling women and increases with age; ~17% of women aged 18-44, >30% over age 60. Stress incontinence predominates in younger women; urge incontinence and mixed types predominate in older women and men with BPH-related urinary symptoms.

🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Urinary Incontinence (Stress, Urge, Overflow) outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Start your 7-day free trial → Sign in

Free to start · No credit card · Cancel anytime

Risk factors

Female sex (stress incontinence; multifactorial)
Age (collagen loss, detrusor changes, comorbidities)
Parity, vaginal childbirth, obstetric injury
Obesity (intra-abdominal pressure)
Pelvic surgery, radiation
Menopause (estrogen deficiency, urogenital atrophy)
Neurologic disease: stroke, multiple sclerosis, spinal cord injury, Parkinson, dementia
Medications: diuretics (urge), alpha-blockers (stress in women), sedatives (functional), opioids (overflow)
Diabetes (neurogenic bladder), prostatic enlargement (overflow), cognitive impairment

Pathophysiology

Stress: urethral hypermobility or intrinsic sphincter deficiency allows leakage when intra-abdominal pressure (cough, sneeze, exertion) exceeds urethral closure pressure. Urge: detrusor overactivity — involuntary detrusor contractions, often idiopathic or related to neurologic disease. Overflow: chronic urinary retention from outlet obstruction (BPH, stricture) or detrusor underactivity (diabetes, neurogenic) causes high post-void residual and continuous overflow leakage. Functional: cognitive or mobility impairment prevents timely toileting.

Clinical presentation

Symptoms

Stress: leakage with cough, sneeze, laugh, exertion, position change
Urge: sudden compelling need to void with inability to defer; large-volume leakage
Mixed: features of both stress and urge
Overflow: continuous or post-void dribbling; weak stream; sensation of incomplete emptying; nocturia
Functional: leakage due to inability to reach toilet (mobility, cognition)

Signs / physical exam

Pelvic exam (women): atrophic vaginitis, prolapse (cystocele, rectocele, uterine prolapse), urethral hypermobility (Q-tip test), pelvic floor strength
Cough stress test — direct leakage with cough at full bladder is diagnostic for stress incontinence
Abdominal exam: distended bladder suggests retention/overflow
DRE in men: enlarged prostate, masses
Neurologic exam: focal deficits, anal sphincter tone (S2-S4)
Post-void residual (PVR) — bladder scan or catheter; >150-200 mL suggests retention

Classic findings

Postmenopausal woman with leakage when coughing or laughing = stress incontinence. Sudden urge with leakage en route to bathroom = urge incontinence.

Differential diagnosis

UTI — Acute onset, dysuria, frequency; positive UA/culture; reversible cause of incontinence
Bladder cancer — Painless hematuria, smoking history; cystoscopy
Vaginal/urethral fistula — Continuous urine leakage from vagina; history of pelvic surgery/childbirth; dye test or imaging
Pelvic organ prolapse — Vaginal bulge sensation, mass on Valsalva, may worsen or 'mask' incontinence
Neurogenic bladder — Spinal cord lesion, MS, diabetes; urodynamic abnormality
BPH (men) — Obstructive and irritative symptoms; enlarged prostate; elevated PVR
Detrusor sphincter dyssynergia — Spinal cord injury between brainstem and sacral cord; urodynamic study diagnostic

Diagnostic workup

Diagnostic criteria

Clinical diagnosis based on history, exam, and basic testing (UA, PVR). Urodynamic studies reserved for refractory cases, mixed picture, neurogenic suspicion, or pre-surgical evaluation. Voiding diary (3-day) quantifies severity and pattern.

Labs

Urinalysis with microscopy — exclude infection, hematuria (bladder cancer)
BMP — assess renal function, glucose (poorly controlled diabetes contributes)
Urine culture if pyuria

Imaging

Post-void residual (PVR) via bladder scan or catheterization — >150-200 mL suggests overflow
Pelvic ultrasound or MRI if pelvic floor disorder, prolapse, or anatomic abnormality suspected
Urodynamic studies — for unclear diagnosis, treatment failure, before invasive treatment

Diagnostic algorithm

Type	Trigger	Mechanism	First-line Treatment
Stress	Cough, sneeze, exertion	Urethral hypermobility / sphincter deficiency	Kegels, weight loss, pessary, midurethral sling
Urge	Sudden compelling need	Detrusor overactivity	Bladder training, antimuscarinic, mirabegron
Mixed	Both	Both	Address most bothersome first
Overflow	Continuous dribbling	Retention (obstruction or underactive detrusor)	Treat cause (BPH, neurogenic); CIC if needed
Functional	Mobility/cognitive	Intact urinary system	Scheduled toileting, OT, environmental aids

Urinary incontinence classification by mechanism, trigger, and first-line treatment.

Treatment

First-line

Lifestyle: weight loss (especially for stress incontinence), fluid management, caffeine and alcohol reduction, smoking cessation
Bladder training (timed voiding, urge suppression techniques) — for urge incontinence
Pelvic floor muscle training (Kegel exercises) ± biofeedback — first-line for stress incontinence (60-70% improvement)
Stress incontinence:
Pessary or urethral plug — non-surgical mechanical support
Midurethral sling (TVT, TVT-O) — most effective definitive treatment
Bulking agents (collagen, calcium hydroxylapatite) — less invasive option
Urge incontinence / overactive bladder:
Behavioral therapy first
Antimuscarinic — oxybutynin, tolterodine, solifenacin, darifenacin, trospium, fesoterodine (caution in elderly — cognitive side effects)
Beta-3 agonist — mirabegron, vibegron (preferred in elderly; no cognitive risk; check BP)
Vaginal estrogen for postmenopausal women with urogenital atrophy

Second-line / adjunct

Refractory urge incontinence:
Onabotulinumtoxin A intravesical injection — for refractory OAB
Sacral neuromodulation (InterStim)
Percutaneous tibial nerve stimulation (PTNS)
Overflow incontinence:
Treat obstruction (alpha-blocker — tamsulosin, alfuzosin, silodosin — for BPH; 5-alpha-reductase inhibitor — finasteride, dutasteride; surgery if refractory)
Clean intermittent catheterization for underactive detrusor
Functional incontinence: occupational therapy, scheduled toileting, environmental modifications, caregiver education
Avoid culprit medications when possible (diuretics, alpha-blockers in women, anticholinergics in elderly)

Complications

Quality of life impact: social isolation, depression, sexual dysfunction
Skin breakdown, dermatitis, pressure ulcers
Recurrent UTI (especially overflow)
Falls (rushing to bathroom, nocturia)
Caregiver burden, institutionalization
Hydronephrosis and renal impairment from chronic retention
Treatment-related: antimuscarinic side effects (dry mouth, constipation, cognitive impairment), surgical complications

PANCE pearls

PVR is essential to distinguish overflow from other types — a key step in workup of any incontinence presentation, especially in older adults.
First-line for stress incontinence: pelvic floor muscle training (Kegels). Midurethral sling is the most effective definitive treatment.
Antimuscarinics (oxybutynin in particular) are on the AGS Beers criteria — high risk of cognitive impairment, dementia, and falls in elderly. Prefer mirabegron or vibegron in older adults.
Mixed incontinence: treat the most bothersome component first.
Reversible causes (DIAPPERS): Delirium, Infection, Atrophic vaginitis, Pharmaceuticals, Psychiatric, Excess urine output, Restricted mobility, Stool impaction.
Overflow incontinence in a man = consider BPH; in a diabetic = consider neurogenic bladder; bladder scan PVR confirms.

References

AUA/SUFU 2019 — Surgical Treatment of Female Stress Urinary Incontinence: AUA/SUFU Guideline (Kobashi et al., J Urol 2017, amended 2019)
AUA/SUFU 2024 — Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2024
ACOG 2019 — ACOG Practice Bulletin No. 155: Urinary Incontinence in Women

Practice Renal/Urology questions on FirstPassPA

Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start studying free → Browse all 514 diagnoses

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.